For retail sale medicaments with alkaloids market in Bulgaria, 2026

Earlier Report Observations

In 2018, the retail market for alkaloid-containing medicaments in Bulgaria was valued at $36.6 million. That January, the Bulgarian drug inspection issued two GMP compliance certificates to 'Alkaloid' AD Skopje, strengthening oversight of alkaloid drug production for human use. The market then contracted sharply to $25.7 million in 2019 and stabilized near $25.4 million in 2020.

After a modest recovery to $26.2 million in 2021, the market volume plunged to $12.5 million in 2022. A partial rebound followed in 2023, reaching $14.5 million, before a significant 35% growth to $19.7 million in 2024. This increase coincided with a government order banning the export of certain vital medicines to ensure national reserves, which limited outbound shipments and supported domestic market volume.

Production for retail sale medicaments with alkaloids in Bulgaria

In value, 2017-2020, K $ US

After two consecutive years of growth, Bulgaria's production of retail sale medicaments containing alkaloids declined. In 2020, output was valued at 33 426 K $ US, marking a 22.9% decrease from the previous year. Production reached its peak in 2019 at 43 337 K $ US, which represented the largest annual increase of 16.2%. Over the entire period from 2017 to 2020, production grew by 3.6%, averaging an annualized rate of 1.2%.

Annual dynamics of production in Bulgaria in value, 2017-2020, K $ US

Exports for retail sale medicaments with alkaloids from Bulgaria

Exports in kind, t

Following two years of growth, Bulgaria's exports of retail sale medicaments with alkaloids declined. In 2020, exports amounted to 641.2 t, showing a sharp drop of 35.5% compared to 2019. The highest export volume was recorded in 2019 at 994.2 t, which also saw the largest annual increase of 23.2%. From 2017 to 2020, exports decreased by 9.1%, with an annualized decline rate of 3.1%.

Annual dynamics of product's exports from Bulgaria in kind, 2017-2020, t

Between 2017 and 2020, Russia, Ukraine, and Kazakhstan were the main markets for Bulgaria's exports of retail sale medicaments with alkaloids in kind. Russia accounted for 41.0% of exports, Ukraine for 14.4%, and Kazakhstan for 6.3%. Together, these three countries represented 61.6% of total export flows.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Bulgaria in kind, 2017-2020

Exports in value, K $ US

After a two-year rise, Bulgaria's exports of retail sale medicaments with alkaloids in value terms declined. In 2020, exports totaled 23 126 K $ US, reflecting a sharp fall of 34.6% from the previous year. The maximum value was achieved in 2019 at 35 363 K $ US, which also recorded the largest annual increase of 28.8%. Over the period 2017-2020, exports decreased by 3.1%, with a compound annual growth rate of -1.1%.

Annual dynamics of product's exports from Bulgaria in value, 2017-2020, K $ US

From 2017 to 2020, the partner landscape for Bulgaria's exports of retail sale medicaments with alkaloids in value terms was diverse. Germany accounted for 23.7% of exports, Russia for 9.8%, and Sweden for 8.3%. Together, these three countries formed 41.9% of total flows, while the remaining 58.1% was distributed among many other countries.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Bulgaria in value, 2017-2020

Imports for retail sale medicaments with alkaloids to Bulgaria

Imports in kind, t

Bulgaria's imports of retail sale medicaments with alkaloids declined for the second consecutive year. In 2020, imports totaled 259.4 t, representing a 10.6% decrease year-over-year. The highest import volume was recorded in 2018 at 318.8 t, which also saw the largest annual increase of 5.2%. Over the period 2017-2020, imports decreased by 14.4%, with a compound annual decline rate of 5.0%.

Annual dynamics of product's imports to Bulgaria in kind, 2017-2020, t

Between 2017 and 2020, Turkey and Hungary dominated Bulgaria's imports of retail sale medicaments with alkaloids in kind, together capturing 90.7% of total imports. The remaining flows were thinly spread across other markets.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Bulgaria in kind, 2017-2020

Imports in value, K $ US

Bulgaria's imports of retail sale medicaments with alkaloids declined for the second year in a row. In 2020, imports were approximately 15 117 K $ US, indicating a robust reduction of 14.8% compared to 2019. The maximum value was recorded in 2018 at 26 755 K $ US, which saw the largest annual increase of 65.6%. In 2019, imports experienced the largest decline of 33.7%. Overall, from 2017 to 2020, imports decreased by 6.4%, averaging an annualized decline rate of 2.2%.

Annual dynamics of product's imports to Bulgaria in value, 2017-2020, K $ US

From 2017 to 2020, Hungary, Poland, and Turkey were the largest sources of Bulgaria's imports of retail sale medicaments with alkaloids in value terms. Hungary accounted for 57.3% of imports, Poland for 16.3%, and Turkey for 10.9%. Together, these three countries comprised 84.5% of total import flows.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Bulgaria in value, 2017-2020